These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
149 related items for PubMed ID: 15200821
1. Multidrug-resistant tuberculosis in central Asia. Cox HS, Orozco JD, Male R, Ruesch-Gerdes S, Falzon D, Small I, Doshetov D, Kebede Y, Aziz M. Emerg Infect Dis; 2004 May; 10(5):865-72. PubMed ID: 15200821 [Abstract] [Full Text] [Related]
2. Risk of acquired drug resistance during short-course directly observed treatment of tuberculosis in an area with high levels of drug resistance. Cox HS, Niemann S, Ismailov G, Doshetov D, Orozco JD, Blok L, Rüsch-Gerdes S, Kebede Y. Clin Infect Dis; 2007 Jun 01; 44(11):1421-7. PubMed ID: 17479936 [Abstract] [Full Text] [Related]
3. Tuberculosis recurrence and mortality after successful treatment: impact of drug resistance. Cox H, Kebede Y, Allamuratova S, Ismailov G, Davletmuratova Z, Byrnes G, Stone C, Niemann S, Rüsch-Gerdes S, Blok L, Doshetov D. PLoS Med; 2006 Oct 01; 3(10):e384. PubMed ID: 17020405 [Abstract] [Full Text] [Related]
4. Multidrug-resistant tuberculosis among previously treated patients in the Philippines. Gler MT, Macalintal LE, Raymond L, Guilatco R, Quelapio MI, Tupasi TE. Int J Tuberc Lung Dis; 2011 May 01; 15(5):652-6. PubMed ID: 21756517 [Abstract] [Full Text] [Related]
5. Multidrug-resistant tuberculosis in Uzbekistan: results of a nationwide survey, 2010 to 2011. Ulmasova DJ, Uzakova G, Tillyashayhov MN, Turaev L, van Gemert W, Hoffmann H, Zignol M, Kremer K, Gombogaram T, Gadoev J, du Cros P, Muslimova N, Jalolov A, Dadu A, de Colombani P, Telnov O, Slizkiy A, Kholikulov B, Dara M, Falzon D. Euro Surveill; 2013 Oct 17; 18(42):. PubMed ID: 24176581 [Abstract] [Full Text] [Related]
6. First-line anti-tuberculosis drug resistance patterns and trends at the national TB referral center in Iran--eight years of surveillance. Shamaei M, Marjani M, Chitsaz E, Kazempour M, Esmaeili M, Farnia P, Tabarsi P, Amiri MV, Mirsaeidi M, Mansouri D, Masjedi MR, Velayati AA. Int J Infect Dis; 2009 Sep 17; 13(5):e236-40. PubMed ID: 19285897 [Abstract] [Full Text] [Related]
7. Compensatory evolution drives multidrug-resistant tuberculosis in Central Asia. Merker M, Barbier M, Cox H, Rasigade JP, Feuerriegel S, Kohl TA, Diel R, Borrell S, Gagneux S, Nikolayevskyy V, Andres S, Nübel U, Supply P, Wirth T, Niemann S. Elife; 2018 Oct 30; 7():. PubMed ID: 30373719 [Abstract] [Full Text] [Related]
8. Surveillance of drug-resistant tuberculosis in the state of Gujarat, India. Ramachandran R, Nalini S, Chandrasekar V, Dave PV, Sanghvi AS, Wares F, Paramasivan CN, Narayanan PR, Sahu S, Parmar M, Chadha S, Dewan P, Chauhan LS. Int J Tuberc Lung Dis; 2009 Sep 30; 13(9):1154-60. PubMed ID: 19723407 [Abstract] [Full Text] [Related]
10. [Frequency of drug resistant tuberculosis in Poland in 2000 as compared to 1997]. Augustynowicz-Kopeć E, Zwolska Z, Jaworski A, Kostrzewa E, Klatt M, Swiderska A, Drozd I. Pneumonol Alergol Pol; 2002 Sep 30; 70(3-4):193-202. PubMed ID: 12271966 [Abstract] [Full Text] [Related]
11. Treatment outcomes for HIV-uninfected patients with multidrug-resistant and extensively drug-resistant tuberculosis. Kwon YS, Kim YH, Suh GY, Chung MP, Kim H, Kwon OJ, Choi YS, Kim K, Kim J, Shim YM, Koh WJ. Clin Infect Dis; 2008 Aug 15; 47(4):496-502. PubMed ID: 18611154 [Abstract] [Full Text] [Related]
12. Primary drug resistance in newly diagnosed smear positive tuberculosis patients in Addis Ababa, Ethiopia. Asmamaw D, Seyoum B, Makonnen E, Atsebeha H, Woldemeskel D, Yamuah L, Addus H, Aseffa A. Ethiop Med J; 2008 Oct 15; 46(4):367-74. PubMed ID: 19271401 [Abstract] [Full Text] [Related]
13. Impact of extensive drug resistance on treatment outcomes in non-HIV-infected patients with multidrug-resistant tuberculosis. Kim HR, Hwang SS, Kim HJ, Lee SM, Yoo CG, Kim YW, Han SK, Shim YS, Yim JJ. Clin Infect Dis; 2007 Nov 15; 45(10):1290-5. PubMed ID: 17968823 [Abstract] [Full Text] [Related]
14. Nationwide survey of anti-tuberculosis drug resistance in Mongolia. Buyankhishig B, Naranbat N, Mitarai S, Rieder HL. Int J Tuberc Lung Dis; 2011 Sep 15; 15(9):1201-5, i. PubMed ID: 21943846 [Abstract] [Full Text] [Related]
15. Multidrug-resistant pulmonary tuberculosis in Los Altos, Selva and Norte regions, Chiapas, Mexico. Sánchez-Pérez HJ, Díaz-Vázquez A, Nájera-Ortiz JC, Balandrano S, Martín-Mateo M. Int J Tuberc Lung Dis; 2010 Jan 15; 14(1):34-9. PubMed ID: 20003692 [Abstract] [Full Text] [Related]
16. Low levels of second-line drug resistance among multidrug-resistant Mycobacterium tuberculosis isolates from Rwanda. Umubyeyi A, Rigouts L, Shamputa IC, Dediste A, Struelens M, Portaels F. Int J Infect Dis; 2008 Mar 15; 12(2):152-6. PubMed ID: 17950021 [Abstract] [Full Text] [Related]
17. Implementation of the INNO-LiPA Rif. TB® line-probe assay in rapid detection of multidrug-resistant tuberculosis in Latvia. Skenders GK, Holtz TH, Riekstina V, Leimane V. Int J Tuberc Lung Dis; 2011 Nov 15; 15(11):1546-52, i. PubMed ID: 22008771 [Abstract] [Full Text] [Related]
18. Risk factors for drug resistant tuberculosis in southeast Turkey. Tanrikulu AC, Hosoglu S, Ozekinci T, Abakay A, Gurkan F. Trop Doct; 2008 Apr 15; 38(2):91-3. PubMed ID: 18453496 [Abstract] [Full Text] [Related]
19. Mycobacterium tuberculosis drug-resistance in previously treated patients in Ouagadougou, Burkina Faso. Sangare L, Diande S, Kouanda S, Dingtoumda BI, Mourfou A, Ouedraogo F, Sawadogo I, Nebie B, Gueye A, Sawadogo LT, Traore AS. Ann Afr Med; 2010 Apr 15; 9(1):15-9. PubMed ID: 20418644 [Abstract] [Full Text] [Related]
20. Recurrence after successful treatment among patients with multidrug-resistant tuberculosis. Lee J, Lim HJ, Cho YJ, Park YS, Lee SM, Yang SC, Yoo CG, Kim YW, Han SK, Yim JJ. Int J Tuberc Lung Dis; 2011 Oct 15; 15(10):1331-3. PubMed ID: 22283890 [Abstract] [Full Text] [Related] Page: [Next] [New Search]